PERSONALIZED IMMUNOTHERAPY AGAINST SEVERAL NEURONAL AND BRAIN TUMORS

The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in com...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hilf, Norbert, Singh, Harpreet, Schoor, Oliver, Song, Colette, Kuttruff-Coqui, Sabrina, Walter, Steffen, Weinschenk, Toni, Fritsche, Jens
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Hilf, Norbert
Singh, Harpreet
Schoor, Oliver
Song, Colette
Kuttruff-Coqui, Sabrina
Walter, Steffen
Weinschenk, Toni
Fritsche, Jens
description The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses. The present invention relates to peptide sequences and their variants derived from HLA class I and class II molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP4253401A3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP4253401A3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP4253401A33</originalsourceid><addsrcrecordid>eNrjZHAJcA0K9vdz9PGMcnVR8PT1DfXzD_FwDXIMiFRwdHf09AsOUQh2DQMK-Cj4uYYGgZQqOPq5KDgFASUVQkJ9_YOCeRhY0xJzilN5oTQ3g4Kba4izh25qQX58anFBYnJqXmpJvGuAiZGpsYmBoaOxMRFKAEEPK8U</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PERSONALIZED IMMUNOTHERAPY AGAINST SEVERAL NEURONAL AND BRAIN TUMORS</title><source>esp@cenet</source><creator>Hilf, Norbert ; Singh, Harpreet ; Schoor, Oliver ; Song, Colette ; Kuttruff-Coqui, Sabrina ; Walter, Steffen ; Weinschenk, Toni ; Fritsche, Jens</creator><creatorcontrib>Hilf, Norbert ; Singh, Harpreet ; Schoor, Oliver ; Song, Colette ; Kuttruff-Coqui, Sabrina ; Walter, Steffen ; Weinschenk, Toni ; Fritsche, Jens</creatorcontrib><description>The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses. The present invention relates to peptide sequences and their variants derived from HLA class I and class II molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20231122&amp;DB=EPODOC&amp;CC=EP&amp;NR=4253401A3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25544,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20231122&amp;DB=EPODOC&amp;CC=EP&amp;NR=4253401A3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Hilf, Norbert</creatorcontrib><creatorcontrib>Singh, Harpreet</creatorcontrib><creatorcontrib>Schoor, Oliver</creatorcontrib><creatorcontrib>Song, Colette</creatorcontrib><creatorcontrib>Kuttruff-Coqui, Sabrina</creatorcontrib><creatorcontrib>Walter, Steffen</creatorcontrib><creatorcontrib>Weinschenk, Toni</creatorcontrib><creatorcontrib>Fritsche, Jens</creatorcontrib><title>PERSONALIZED IMMUNOTHERAPY AGAINST SEVERAL NEURONAL AND BRAIN TUMORS</title><description>The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses. The present invention relates to peptide sequences and their variants derived from HLA class I and class II molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHAJcA0K9vdz9PGMcnVR8PT1DfXzD_FwDXIMiFRwdHf09AsOUQh2DQMK-Cj4uYYGgZQqOPq5KDgFASUVQkJ9_YOCeRhY0xJzilN5oTQ3g4Kba4izh25qQX58anFBYnJqXmpJvGuAiZGpsYmBoaOxMRFKAEEPK8U</recordid><startdate>20231122</startdate><enddate>20231122</enddate><creator>Hilf, Norbert</creator><creator>Singh, Harpreet</creator><creator>Schoor, Oliver</creator><creator>Song, Colette</creator><creator>Kuttruff-Coqui, Sabrina</creator><creator>Walter, Steffen</creator><creator>Weinschenk, Toni</creator><creator>Fritsche, Jens</creator><scope>EVB</scope></search><sort><creationdate>20231122</creationdate><title>PERSONALIZED IMMUNOTHERAPY AGAINST SEVERAL NEURONAL AND BRAIN TUMORS</title><author>Hilf, Norbert ; Singh, Harpreet ; Schoor, Oliver ; Song, Colette ; Kuttruff-Coqui, Sabrina ; Walter, Steffen ; Weinschenk, Toni ; Fritsche, Jens</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP4253401A33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>Hilf, Norbert</creatorcontrib><creatorcontrib>Singh, Harpreet</creatorcontrib><creatorcontrib>Schoor, Oliver</creatorcontrib><creatorcontrib>Song, Colette</creatorcontrib><creatorcontrib>Kuttruff-Coqui, Sabrina</creatorcontrib><creatorcontrib>Walter, Steffen</creatorcontrib><creatorcontrib>Weinschenk, Toni</creatorcontrib><creatorcontrib>Fritsche, Jens</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Hilf, Norbert</au><au>Singh, Harpreet</au><au>Schoor, Oliver</au><au>Song, Colette</au><au>Kuttruff-Coqui, Sabrina</au><au>Walter, Steffen</au><au>Weinschenk, Toni</au><au>Fritsche, Jens</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PERSONALIZED IMMUNOTHERAPY AGAINST SEVERAL NEURONAL AND BRAIN TUMORS</title><date>2023-11-22</date><risdate>2023</risdate><abstract>The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses. The present invention relates to peptide sequences and their variants derived from HLA class I and class II molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP4253401A3
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title PERSONALIZED IMMUNOTHERAPY AGAINST SEVERAL NEURONAL AND BRAIN TUMORS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T00%3A22%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Hilf,%20Norbert&rft.date=2023-11-22&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP4253401A3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true